Task: Answer the MCQ question.
Query: Which drug exhibits a 17.492% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
[a] Cc1cc(C)nc(-n2nc(C)cc2NC(=O)C(C)C)n1
[b] CCOc1cc(/C=N/NC(=O)C2CCCC2)ccc1OC(C)C
[c] COc1ccccc1C(C#N)N1N=C(C)CC1(C)C
[d] Cl.Nc1ccc(C(=O)N/N=C2/CN3CCC2CC3)cc1
Answer: b. CCOc1cc(/C=N/NC(=O)C2CCCC2)ccc1OC(C)C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1cc(/C=N/NC(=O)C2CCCC2)ccc1OC(C)C
CCOc1cc(/C=N/NC(=O)C2CCCC2)ccc1OC(C)C
N-[(E)-(3-ethoxy-4-propan-2-yloxyphenyl)methylideneamino]cyclopentanecarboxamide